Delivery Order SPE2DB22D1106-SPE2DB24FDYC6
Award Date 1/31/24
Potential Completion Date 2/1/24
Potential Value $7.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of Ondansetron HCL 8 mg tablets. The fixed-price contract has a ceiling value of $1,472.38 and an ultimate completion date of January 8, 2024. This delivery order is placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
- This federal contract award, valued at $26,805.03, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract covers the delivery of 4,564,478,867 units of Ondansetron HCL 8 mg tablets to support military healthcare programs. The award is a firm-fixed-price delivery order contract with a completion date of May 3, 2024. This order is part of a larger...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,563,004,559 units of Ondansetron HCL 8 mg tablets. The $36,499.81 firm fixed-price contract was awarded on December 5, 2023 by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency. The award is not associated with a set-aside designation, indicating open competition. This delivery order is issued under Amerisourcebergen's $999,999,999 Indefinite Delivery...
- This federal contract award, valued at $3,379.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of 4,560,993,787 units of Ondansetron ODT 4 mg Tablet 30s, a pharmaceutical product. The contract has an ultimate completion date of May 22, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award, valued at $5,099.98, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order to supply 4560940691 - Ondansetron HCL 8 mg Tablets in quantities of 30 for the Department of Defense (DoD) and other federal agencies. The award has a completion date of May 16, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,563,774,936 units of Ondansetron HCL 4 mg tablets. The award, valued at $2,928.70, is a delivery order with a firm fixed price. The contract does not have any set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,559,785,987 units of the medication Ondansetron HCL 8 mg tablets. The contract has a ceiling value of $2,998.85 and a completion date of February 1, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
- This federal contract award, valued at $9,782.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,564,416,379 units of Ondansetron HCL 4 mg Tablets in 30-count packages. This is a delivery order contract with a firm fixed-price pricing type, with a completion date of April 29, 2024. The contract does not have a set-aside designation, indicating it was awarded through full and open competition....
- This federal contract award, valued at $4,235.33, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,559,735,862 units of the pharmaceutical product Ondansetron HCL 4 mg Tablet in 30-count packages. The contract has a completion date of January 27, 2023 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,457.17, is for the delivery of Ondansetron HCL 8 mg tablets in 30 count packages. The contract is a Firm Fixed Price Delivery Order with a completion date of February 28, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract...